In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 0.1% to 9,079.8 points.
Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:
Image source: Getty Images
AMP Ltd (ASX: AMP)
The AMP share price is up 10% to $1.94. This follows the release of the financial services company's third quarter update this morning. AMP revealed that its total assets under management (AUM) increased 3.6% quarter on quarter to $159.5 billion. This was driven by its Platforms AUM, which increased 4.5% to $86.9 billion. Management notes that this reflects resilient inflows and positive investment markets. In addition, it revealed that Platforms net cashflows increased by 61.6% over the prior corresponding period to $1.2 billion. AMP's chief executive, Alexis George, said: "In Platforms, the strength of the North proposition continues to be recognised by advisers, with net cashflows up over 60% on pcp and AUM reaching close to $87 billion."
GQG Partners Inc (ASX: GQG)
The GQG Partners share price is up almost 7% to $1.64. This morning, this fund manager announced its next quarterly dividend. GQG Partners intends to pay shareholders the equivalent of 5.6775 cents per share in December. This quarterly dividend equates to an attractive 3.4% dividend yield. Annualised, this would mean dividends of 22.71 cents per share, which is the equivalent of a 13.8% dividend yield.
Jumbo Interactive Ltd (ASX: JIN)
The Jumbo share price is up a further 10% to $11.82. Investors have been bidding this online lottery ticket seller's shares higher this week after it announced a major acquisition. Jumbo is paying $110 million to acquire UK-based Dream Car Giveaways. It is a leading business-to-consumer (B2C) brand and digital market proposition in the UK prize draw market, allowing customers to compete for prizes such as cars, cash, property, and lifestyle products. Commenting on the deal, Jumbo's CEO, Mike Veverka, said: "Jumbo's two decades of B2C success in Australia and its world-class software, marketing, and customer management expertise, provides DCG with the foundation to continue its already impressive growth."
Mayne Pharma Group Ltd (ASX: MYX)
The Mayne Pharma share price is up 11% to $6.30. This follows news that the pharmaceuticals company won a court battle against Cosette Pharmaceuticals. The latter has been looking to back out of a takeover deal this year, but the New South Wales Supreme Court has ruled in its favour that no material adverse change had occurred. Mayne Pharma's shares are still trading well short of the $7.40 takeover price, which could be an indication that not everyone is convinced the deal is a foregone conclusion.
